اثر درمانی پالس سیکلوفسفامید وریدی در رمیسیون کلیوی بیماران مبتلا به نفریت لوپوسی پرولیفراتیو
Authors
Abstract:
Background: Lupus nephritis, especially diffuse proliferative type is one of the potentially life threatening disabling consequences of SLE that needs intensive and invasive treatment. As there is not enough information available about the results of Intravenous Cyclophamide (IVC) therapy on these patients in our country, this study was performed from 1997 to 2002 in Esfahan Azzahra Hospital. Materials and Methods: In this semi-experimental study 14 hospitalized patients with Diffuse Proliferative Glomerulonephritis (DPGN) were treated with IVC, and the efficacy of IVC was investigated by evaluation of urine sediment, serum urea, creatinin, and urinary excretion of creatinin and protein. The results were evaluated after 6,12 and 24 months of IVC therapy again. All of the data were analyzed by paired t-test and Chi - square test. Results: 3 patients were excluded and 14 patients were studied. Partial remission was seen in 5 patients (33.4%) after 6 months, and in one patient (7.1%) after 12 months of IVC therapy. There was not any cases of partial remission after 24 months of treatment. The rate of complete remission in 6th, 12th and 24th months of study were 14.3%, 28.6% and 28.6%. The cumulative frequency of complete remission cases in 6th, 12th and 24th months of study were 14.3%, 42.9% and 71.4%. In general, only 3 (21.4%) cases continued to have proteinuria in the range of nephrotic syndrome after 24 months of treatment. The average interval to achieve partial remission was 7.7 2.9 months and for complete remission was 15.6 7.59 months. Conclusion: Most cases with diffuse proliferative lupus nephritis achieved complete remission after 2 years (71.4%) of IVC therapy. So we recommend this treatment for all patients with lupus induced diffuse proliferative glumerolonephritis.
similar resources
نتایج درمان نفریت لوپوسی پرولیفراتیو مقاوم به درمان با سیکلوسپورین A
Background & Aims: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by various autoantibodies formation and immune complex deposition in various organs. Lupus nephritis is a common and severe manifestation of SLE that can lead to end stage renal disease and death. The aim of this study was to evaluate the long-term efficacy of cyclosporine A in the treat...
full textنتایج درمان نفریت لوپوسی پرولیفراتیو مقاوم به درمان با سیکلوسپورین a
پیش زمینه و هدف: نفریت لوپوسی یکی از تظاهرات شایع و شدید بیماری لوپوس اریتماتوس سیستمیک است که می تواند منجر به نارسایی کلیه و حتی مرگ بیمار گردد. حداقل 30-20درصد از موارد نفریت لوپوسی پرولیفراتیو به درمان استاندارد پاسخ نمی دهند. برای درمان این بیماران روش های مختلفی پیشنهادشده ولی در مورد هیچ کدام از آن ها توافق عمومی وجود ندارد. هدف از این مطالعه بررسی نتایج درمان با سیکلوسپورین در درمان نفر...
full textفاکتورهای پروگنوستیک در کودکان مبتلا به نفریت لوپوسی مرکز طبی کودکان ، 77-1368
Background: Despite several years of intensive investigation, relatively few studies have been made of children with lupus nephritis. The prognosis of children with lupus nephritis is poor for those with diffuse proliferative glomerulonephritis and active interstitial inflammation. As newer treatment modalities become available for patients with severe lupus nephritis, it become increasingly im...
full textپیش آگهی در کودکان مبتلا به نفریت لوپوسی
مقدمه: بیماری لوپوس اریتروماتوزوس یک بیماری سیستمیک است که ارگانهای مختلف را درگیر می کند. مطالعه حاضر به منظور بررسی نفریت لوپوسی در کودکان، سرانجام آن و فاکتورهای مرتبط با سرانجام آن صورت گرفته است. روش کار: مطالعه گذشته نگر بر روی 48 کودک مبتلا به نفریت لوپوسی با مراجعه به پرونده بیمارستانی آنان صورت گرفته است. خصوصیات بالینی و اپیدمولوژیک، سرانجام بیماران در مدت پیگیری ثبت گردیده و فاکتورها...
full textMy Resources
Journal title
volume 10 issue 40
pages 17- 23
publication date 2002-09
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023